WOCKPHARMA Wockhardt Ltd Earnings Reports Announcement 2024 - Earnings Results WOCKHARDT LTD. reported 14% YoY growth in revenue of INR 747 Cr in Q1FY25 and 216% YoY growth in EBITDA of INR 100 Cr. Clinical trials for ZAYNICH antibiotic progressing well with 100% cure rate..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Wockhardt Ltd